{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:49:30Z","timestamp":1776106170627,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["81401847"],"award-info":[{"award-number":["81401847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s13277-015-4273-6","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T15:15:58Z","timestamp":1445354158000},"page":"57-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The role of TARBP2 in the development and progression of cancers"],"prefix":"10.1007","volume":"37","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"4273_CR1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/ng1010-817","volume":"42","author":"P Garre","year":"2010","unstructured":"Garre P, Perez-Segura P, Diaz-Rubio E, Caldes T, de la Hoya M. Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer. Nat Genet. 2010;42:817\u20138. author reply 818.","journal-title":"Nat Genet"},{"key":"4273_CR2","doi-asserted-by":"crossref","first-page":"9766","DOI":"10.1074\/jbc.M114.557066","volume":"289","author":"J Zimmermann","year":"2014","unstructured":"Zimmermann J, Latta L, Beck A, Leidinger P, Fecher-Trost C, Schlenstedt G, et al. Trans-activation response (TAR) RNA-binding protein 2 is a novel modulator of transient receptor potential canonical 4 (TRPC4) protein. J Biol Chem. 2014;289:9766\u201380.","journal-title":"J Biol Chem"},{"key":"4273_CR3","doi-asserted-by":"crossref","first-page":"48803","DOI":"10.1074\/jbc.M104645200","volume":"276","author":"S Bannwarth","year":"2001","unstructured":"Bannwarth S, Talakoub L, Letourneur F, Duarte M, Purcell DF, Hiscott J, et al. Organization of the human tarbp2 gene reveals two promoters that are repressed in an astrocytic cell line. J Biol Chem. 2001;276:48803\u201313.","journal-title":"J Biol Chem"},{"key":"4273_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng.317","volume":"41","author":"SA Melo","year":"2009","unstructured":"Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet. 2009;41:365\u201370.","journal-title":"Nat Genet"},{"key":"4273_CR5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mc.20861","volume":"51","author":"M Sand","year":"2012","unstructured":"Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, et al. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. 2012;51:916\u201322.","journal-title":"Mol Carcinog"},{"key":"4273_CR6","doi-asserted-by":"crossref","unstructured":"de Sousa GR, Ribeiro TC, Faria AM, Mariani BM, Lerario AM, Zerbini MC, Soares IC, Wakamatsu A, Alves VA, Mendonca BB, Fragoso MC, Latronico AC, Almeida MQ. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma. Oncotarget. 2015.","DOI":"10.18632\/oncotarget.4261"},{"key":"4273_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0888-7543(95)80110-8","volume":"25","author":"CA Kozak","year":"1995","unstructured":"Kozak CA, Gatignol A, Graham K, Jeang KT, McBride OW. Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1). Genomics. 1995;25:66\u201372.","journal-title":"Genomics"},{"key":"4273_CR8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/ERC-13-0098","volume":"20","author":"S Caramuta","year":"2013","unstructured":"Caramuta S, Lee L, Ozata DM, Akcakaya P, Xie H, Hoog A, et al. Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma. Endocr Relat Cancer. 2013;20:551\u201364.","journal-title":"Endocr Relat Cancer"},{"key":"4273_CR9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1309\/AJCPBSLP8XHSWLOW","volume":"139","author":"S Bai","year":"2013","unstructured":"Bai S, Nunez AL, Wei S, Ziober A, Yao Y, Tomaszewski JE, et al. Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma. Am J Clin Pathol. 2013;139:765\u201370.","journal-title":"Am J Clin Pathol"},{"key":"4273_CR10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccr.2012.04.023","volume":"21","author":"C Vito De","year":"2012","unstructured":"De Vito C, Riggi N, Cornaz S, Suva ML, Baumer K, Provero P, et al. A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. Cancer Cell. 2012;21:807\u201321.","journal-title":"Cancer Cell"},{"key":"4273_CR11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4161\/epi.24519","volume":"8","author":"E Sousa","year":"2013","unstructured":"Sousa E, Graca I, Baptista T, Vieira FQ, Palmeira C, Henrique R, et al. Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing. Epigenetics. 2013;8:548\u201358.","journal-title":"Epigenetics"},{"key":"4273_CR12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-012-1446-0","volume":"350","author":"M Sand","year":"2012","unstructured":"Sand M, Skrygan M, Georgas D, Sand D, Gambichler T, Altmeyer P, et al. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi. Cell Tissue Res. 2012;350:119\u201326.","journal-title":"Cell Tissue Res"},{"key":"4273_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/path.2683","volume":"221","author":"MS Kim","year":"2010","unstructured":"Kim MS, Oh JE, Kim YR, Park SW, Kang MR, Kim SS, et al. Somatic mutations and losses of expression of microRNA regulation-related genes AGO2 and TNRC6A in gastric and colorectal cancers. J Pathol. 2010;221:139\u201346.","journal-title":"J Pathol"},{"key":"4273_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/9684","volume":"22","author":"J Zhong","year":"1999","unstructured":"Zhong J, Peters AH, Lee K, Braun RE. A double-stranded RNA binding protein required for activation of repressed messages in mammalian germ cells. Nat Genet. 1999;22:171\u20134.","journal-title":"Nat Genet"},{"key":"4273_CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature13466","volume":"513","author":"H Goodarzi","year":"2014","unstructured":"Goodarzi H, Zhang S, Buss CG, Fish L, Tavazoie S, Tavazoie SF. Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins. Nature. 2014;513:256\u201360.","journal-title":"Nature"},{"key":"4273_CR16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s12032-014-0868-9","volume":"31","author":"X Lin","year":"2014","unstructured":"Lin X, Wu M, Liu P, Wei F, Li L, Tang H, et al. Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer. Med Oncol. 2014;31:868.","journal-title":"Med Oncol"},{"key":"4273_CR17","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1038\/bcj.2013.49","volume":"3","author":"S Caramuta","year":"2013","unstructured":"Caramuta S, Lee L, Ozata DM, Akcakaya P, Georgii-Hemming P, Xie H, et al. Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma. Blood Cancer J. 2013;3:e152.","journal-title":"Blood Cancer J"},{"key":"4273_CR18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00204-015-1474-0","volume":"89","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto H, Imai K. Microsatellite instability: an update. Arch Toxicol. 2015;89:899\u2013921.","journal-title":"Arch Toxicol"},{"key":"4273_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urolonc.2010.07.016","volume":"31","author":"F Audenet","year":"2013","unstructured":"Audenet F, Yates DR, Cussenot O, Roupret M. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). Urol Oncol. 2013;31:407\u201313.","journal-title":"Urol Oncol"},{"key":"4273_CR20","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1158\/0008-5472.CAN-14-1106","volume":"74","author":"S Cornaz-Buros","year":"2014","unstructured":"Cornaz-Buros S, Riggi N, DeVito C, Sarre A, Letovanec I, Provero P, et al. Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma. Cancer Res. 2014;74:6610\u201322.","journal-title":"Cancer Res"},{"key":"4273_CR21","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1038\/ncomms5039","volume":"5","author":"GT Torrezan","year":"2014","unstructured":"Torrezan GT, Ferreira EN, Nakahata AM, Barros BD, Castro MT, Correa BR, et al. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour. Nat Commun. 2014;5:4039.","journal-title":"Nat Commun"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4273-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4273-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:43:41Z","timestamp":1559475821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4273-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["4273"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4273-6","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]}}}